NHS Genomic Medicine Service - Most Suitable Provider Process

What this is

This is an Intended Approach Notice to award contracts using the Most Suitable Provider (MSP) process for the NHS Genomic Medicine Service (NHS GMS). The draft specification defines an integrated set of functions to be provided cohesively, including organisational leadership/governance, delivery of genomic testing per the National Genomic Test Directory, laboratory operating model, clinical functions (cancer genomics, rare disease, population health), science/research/innovation, transformation, workforce/education, and data/digital. The Commissioner expects only NHS organisations can meet the full set of requirements (due to integration with NHS operations, governance and pathways) and these are under consideration as Most Suitable Providers. Assessment is pass/fail against quality and innovation, value, integration/collaboration/sustainability, improving access/reducing inequalities, and social value. EoI Questionnaires and Declarations are due by 12pm midday Thursday 21 August 2025 (project ref C368833).

Key points

• MSP process for the NHS Genomic Medicine Service (integrated function set)
• Expected only NHS organisations can meet the full requirements; pass/fail assessment
• EoI deadline 12pm 21 August 2025; estimated value GBP 3.85bn

Who can bid

Providers must demonstrate experience, expertise, capability and readiness across all NHS GMS functions; expected to be NHS organisations.

How it is scored

Pass/fail assessment on basic selection criteria plus quality and innovation, value, integration/collaboration/sustainability, improving access and reducing inequalities, and social value.

How to submit

Register on the e-Tendering portal (project ref C368833) to access MSP documentation; EoI Questionnaires and Declarations due 12pm midday Thursday 21 August 2025.

Classification

CPV 85100000 — Health services Yorkshire and the Humber